ArticleBritish journal of cancer2024
Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer.
Hiroshi Kikuchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it